Jiro Abe

918 total citations
47 papers, 732 citations indexed

About

Jiro Abe is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Jiro Abe has authored 47 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Jiro Abe's work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Diagnosis and Treatment (11 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Jiro Abe is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Diagnosis and Treatment (11 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Jiro Abe collaborates with scholars based in Japan, United States and Canada. Jiro Abe's co-authors include Ikuro Sato, Satomi Takahashi, Keiichi Tamai, Kennichi Satoh, Takayuki Nakagawa, Hiroyuki Endo, Misa Yokoyama, Takashi Kondo, Nobuyuki Tanaka and Yoshinori Okada and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Jiro Abe

39 papers receiving 726 citations

Peers

Jiro Abe
Yongyou Wu China
Amir Aledavood Iran
Yuejiao Zhong China
Venkateswara Rao Gogineni United States
Laure Humbert Canada
Weiyuan Wang China
Guanglei Qiao China
Xiumei Ma China
Zi-Qi Zhou China
Hiroshi Shirahama Japan
Yongyou Wu China
Jiro Abe
Citations per year, relative to Jiro Abe Jiro Abe (= 1×) peers Yongyou Wu

Countries citing papers authored by Jiro Abe

Since Specialization
Citations

This map shows the geographic impact of Jiro Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Abe more than expected).

Fields of papers citing papers by Jiro Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiro Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Abe. The network helps show where Jiro Abe may publish in the future.

Co-authorship network of co-authors of Jiro Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Abe. A scholar is included among the top collaborators of Jiro Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Abe. Jiro Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saito, Ryoko, Yasuhiro Miki, Chihiro Inoue, et al.. (2024). Prognostic significance and response to immune checkpoint inhibitors of RIPK3, MLKL and necroptosis in non-small cell lung cancer. Scientific Reports. 14(1). 21625–21625. 6 indexed citations
2.
Kato, Hirohisa, Satoshi Shiono, Hiroyuki Suzuki, et al.. (2024). A prospective 10-year follow-up study after sublobar resection for ground-glass opacity-dominant lung cancer. Scientific Reports. 14(1). 21243–21243.
3.
Onodera, Ken, Isao Yokota, Yuki Matsumura, et al.. (2023). Efficacy of platinum-based adjuvant chemotherapy for epidermal growth factor receptor-mutant lung adenocarcinoma. Journal of Thoracic Disease. 15(12). 6534–6543.
4.
Hayasaka, Kazuki, Haruna Takeda, Akira Sakurada, et al.. (2023). Clinical, Genomic, and Transcriptomic Featurses of Lung Adenocarcinoma With Uncommon EGFR Mutation. Clinical Lung Cancer. 25(1). e43–e51.
5.
Mochizuki, Mai, Norihisa Shindo, Kazunori Yamaguchi, et al.. (2023). CD271 promotes proliferation and migration in bladder cancer. Genes to Cells. 29(1). 73–85.
6.
Ito, Shin, Ikuro Sato, Jiro Abe, et al.. (2023). Clinical and genomic features of non‐small cell lung cancer occurring in families. Thoracic Cancer. 14(10). 940–952. 2 indexed citations
7.
Soga, Tomoyoshi, Miyuki Nomura, Taku Sato, et al.. (2020). Comparison of the ischemic and non-ischemic lung cancer metabolome reveals hyper activity of the TCA cycle and autophagy. Biochemical and Biophysical Research Communications. 530(1). 285–291. 5 indexed citations
8.
Abe, Jiro, et al.. (2020). Morphological magnetic resonance imaging study of oral submucosal tissue and buccinator muscle dynamics in the posterior dentition: A clinical study. Journal of Prosthetic Dentistry. 125(5). 759–765. 1 indexed citations
9.
Abe, Jiro, Yuji Matsumura, Satoshi Shiono, et al.. (2020). Validation of the Proposed cN2 Subclassification in the Eighth Edition of the IASLC Staging System: A Prospective Phase II Multicenter Study. JTO Clinical and Research Reports. 1(2). 100019–100019. 2 indexed citations
10.
11.
Mochizuki, Mai, Jiro Abe, Takayuki Nakagawa, et al.. (2019). CD271 is a negative prognostic factor and essential for cell proliferation in lung squamous cell carcinoma. Laboratory Investigation. 99(9). 1349–1362. 11 indexed citations
12.
Onodera, Ken, Akira Sakurada, Jiro Abe, et al.. (2019). Clinicopathological features of intraoperative pleural lavage cytology for non-small cell lung cancer. General Thoracic and Cardiovascular Surgery. 68(2). 164–169. 1 indexed citations
13.
Abe, Jiro, Nobuhiro Tanuma, Miyuki Nomura, et al.. (2019). Novel activating KRAS mutation candidates in lung adenocarcinoma. Biochemical and Biophysical Research Communications. 522(3). 690–696. 1 indexed citations
14.
Okazaki, Takahito, Keiichi Tamai, Rie Shibuya, et al.. (2018). P1.03-31 Periostin is a Negative Prognostic Factor and Promotes Cancer Cell Proliferation in Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 13(10). S523–S524. 1 indexed citations
15.
Abe, Jiro, et al.. (2018). Preoperative bronchoscopic cancer confirmation does not increase risk of recurrence in stage1A non-small cell lung cancer. General Thoracic and Cardiovascular Surgery. 66(5). 284–290. 4 indexed citations
16.
Hayasaka, Kazuki, Satoshi Shiono, Yuki Matsumura, et al.. (2017). OA19.07 Difference of Postoperative Survival Due to the Type of EGFR Gene Mutation in Surgically Resected Lung Adenocarcinomas. Journal of Thoracic Oncology. 12(1). S320–S321.
17.
Nakagawa, Takayuki, Hiroyuki Endo, Misa Yokoyama, et al.. (2013). Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer. Biochemical and Biophysical Research Communications. 436(2). 319–324. 224 indexed citations
18.
19.
Saito, Yasuki, et al.. (2011). A case of locally recurrent chest wall desmoid tumor effectively treated with radiotherapy. The Journal of the Japanese Association for Chest Surgery. 25(6). 672–677. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongyou Wu Breakdown of academic impact, for papers by Amir Aledavood Breakdown of academic impact, for papers by Yuejiao Zhong Breakdown of academic impact, for papers by Venkateswara Rao Gogineni Breakdown of academic impact, for papers by Laure Humbert Breakdown of academic impact, for papers by Weiyuan Wang Breakdown of academic impact, for papers by Guanglei Qiao Breakdown of academic impact, for papers by Xiumei Ma Breakdown of academic impact, for papers by Zi-Qi Zhou Breakdown of academic impact, for papers by Hiroshi Shirahama
Rankless by CCL
2026